pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,460 catalysts · 3,382 8k filing · 2,401 grant · 2,059 approval · 1,416 device 510k · 1,000 device adverse event · 949 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×from 2025-10-30×clear all
type
  • 8k filing3,382
  • grant2,401
  • approval2,059
  • device 510k1,416
  • device adverse event1,000
  • device recall949
device pma
941
  • earnings584
  • recall364
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Oct 27, 2025

    34
    ›Oct 30, 2025approval292d agoTYRUKO (NATALIZUMAB-SZTN) — FDA approvalnatalizumab biosimilar

    Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

    full page →natalizumab biosimilar →fda approvals ↗
    ›Oct 30, 2025approval292d agoVIMIZIM (ELOSULFASE ALFA) — FDA approvalBIOMARIN PHARMACEUTICAL INC

    Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 30, 2025approval292d agoHALDOL (HALOPERIDOL DECANOATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 30, 2025approval292d agoAXITINIB — FDA approvalaxitinib SR

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →axitinib SR →fda approvals ↗
    ›Oct 30, 2025approval292d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

    Sponsor: NOVUGEN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2025approval291d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

    Sponsor: CHARTWELL RX. Form: FOR SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2025approval291d agoVOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approvalamoxicillin + clarithromycin + vonoprazan

    Sponsor: PHATHOM. Form: CAPSULE, TABLET, TABLET. Route: ORAL

    full page →amoxicillin + clarithromycin + vonoprazan →fda approvals ↗
    ›Oct 31, 2025approval291d agoVOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approvalamoxicillin + vonoprazan fumarate

    Sponsor: PHATHOM. Form: CAPSULE, TABLET. Route: ORAL

    full page →amoxicillin + vonoprazan fumarate →fda approvals ↗
    ›Oct 31, 2025approval291d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 31, 2025approval291d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF COLORADO DENVER — Enhancement of Effector CD8 Cell Motility through Mitochondrial MetabolismUniversity of Colorado Denver

    AI grant. $38,093. PI: Maureen E Hoen Rauhut

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoYALE UNIVERSITY — Impact of Natural Infection on the Baseline Immune States in Humans

    AI grant. $34,558. PI: Yona Lei

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoEMORY UNIVERSITY — Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirusEmory University

    AI grant. $78,052. PI: Shea Lowery

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoPRINCETON UNIVERSITY — Molecular and Cellular Determinants of Tolerance to Second Generation Antipsy...

    MH grant. $33,538. PI: Elinor Lewis

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoBROWN UNIVERSITY — TAC1 Tango: Evolutionary rewiring of a transcriptional circuit for azole drug...

    AI grant. $75,520. PI: Nicholas Cauldron

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $19,000. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Oral Microbiome Dysregulation as a Contributor to Depressive Symptoms and Alt...University of California Los Angeles

    MH grant. $42,489. PI: Naomi Gancz

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoJOHNS HOPKINS UNIVERSITY — Microbiota mechanisms promoting Clostridioides difficile colon persistenceJohns Hopkins University

    AI grant. $49,538. PI: Hadley Beauregard

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoHARVARD MEDICAL SCHOOL — Molecular Transport of IFT Complexes in Leishmania

    AI grant. $44,020. PI: Tierra Buck

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — How does myelin plasticity influence neural circuit dynamics required for lon...University of California San Francisco

    MH grant. $75,052. PI: Manasi Iyer

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

    AI grant. $99,429. PI: JASON B HARRIS

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Longitudinal Impact of Health and Lifestyle Behaviors on Cognition in Individ...

    HD grant. $75,600. PI: Michelle H Chen

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Syphilis Immunology and Biology to Improve Clinical Management and Vaccine De...University of Southern California

    AI grant. $238,136. PI: Jeffrey David Klausner

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF TEXAS MED BR GALVESTON — Initiate Research, Opportunities, and Networks for Early Career Investigators...

    DK grant. $103,081. PI: Brittany L. Smalls

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Triggers of food allergen absorption and anaphylaxisNorthwestern University

    AI grant. $53,461. PI: Danielle Rose Jacobsen

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoEMORY UNIVERSITY — Molecular determinants of Streptococcus pyogenes adhesion to pyroptotic kerat...Emory University

    AI grant. $49,538. PI: Jacob D Sherman

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoVANDERBILT UNIVERSITY MEDICAL CENTER — All of Us Research Program Data and Research Center

    OD grant. $2,500,000. PI: Melissa Basford

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF IOWA — Developing real-time personalized TMS to target residual corticospinal connec...University of Iowa

    NS grant. $245,687. PI: Sara J Hussain

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoOHIO STATE UNIVERSITY — Epigenetic Regulation of KSHV

    AI grant. $85,360. PI: Kurtis Matthew Host

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoJOHNS HOPKINS UNIVERSITY — Chemosensory Mechanisms Driving Malaria TransmissionJohns Hopkins University

    AI grant. $103,760. PI: Conor James McMeniman

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — 2025 Rachmiel Levine-Arthur Riggs Diabetes Research SymposiumCity of Hope

    DK grant. $20,000. PI: FOUAD R KANDEEL

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoUNIVERSITY OF CALIFORNIA BERKELEY — Elucidating the mechanism and correlates of protection elicited by CDN adjuva...

    AI grant. $48,395. PI: Isabel Lamb-Echegaray

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Strategies and Consequences of Polymicrobial Nasal Colonization

    AI grant. $75,520. PI: Shyra Wilde

    full page →nih reporter ↗
    ›Nov 1, 2025grant290d agoSTANFORD UNIVERSITY — Predicting Japanese Encephalitis Spillover Risk in the United StatesStanford University

    AI grant. $75,052. PI: Rachel Lucy Fay

    full page →nih reporter ↗

    Week of Nov 3, 2025

    16
    ›Nov 3, 2025approval288d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Nov 3, 2025approval
    ← prev
    page 1 of 90
    next →
    288d ago
    STELARA (USTEKINUMAB) — FDA approvalustekinumab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →ustekinumab →fda approvals ↗
    ›Nov 3, 2025approval288d agoNIPENT (PENTOSTATIN) — FDA approvalpentostatin

    Sponsor: HOSPIRA INC. Form: INJECTABLE. Route: INJECTION

    full page →pentostatin →fda approvals ↗
    ›Nov 3, 2025approval288d agoBREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approvalibrexafungerp citrate

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →ibrexafungerp citrate →fda approvals ↗
    ›Nov 3, 2025approval288d agoCISATRACURIUM BESYLATE — FDA approvalCISATRACURIUM BESYLATE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →CISATRACURIUM BESYLATE →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN — FDA approvalBoehringer Ingelheim Corp

    Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN — FDA approvalLINAGLIPTIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval288d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalLINAGLIPTIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →LINAGLIPTIN →fda approvals ↗
    ›Nov 3, 2025approval288d agoESLICARBAZEPINE ACETATE — FDA approvalShanghai Zhongxi Pharmaceutical Co Ltd

    Sponsor: SPH ZHONGXI PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 3, 2025approval288d agoKYGEVVI (DOXECITINE) — FDA approval(doxecitine + doxribtimine)

    Sponsor: UCB INC. Form: FOR SOLUTION. Route: ORAL

    full page →(doxecitine + doxribtimine) →fda approvals ↗
    ›Nov 3, 2025approval288d agoTRIMIPRAMINE MALEATE — FDA approvalTRIMIPRAMINE MALEATE

    Sponsor: BRECKENRIDGE. Form: CAPSULE. Route: ORAL

    full page →TRIMIPRAMINE MALEATE →fda approvals ↗
    ›Nov 4, 2025approval287d agoMEDROL (METHYLPREDNISOLONE) — FDA approvalMEDROL

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    ›Nov 4, 2025approval287d agoISOFLURANE — FDA approvalSedana Medical AB

    Sponsor: SHANDONG. Form: LIQUID. Route: INHALATION

    full page →fda approvals ↗
    $PHAT9.2800-3.13%
    $PHAT9.2800-3.13%
    $JNJ262.37+0.78%
    $BMRN66.64-1.07%
    $PFE26.87+0.30%